Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Radiation Injuries 1

Interventions

pembrolizumab 259 Cyclophosphamide 242 Specimen Handling 199 fludarabine 174 Magnetic Resonance Spectroscopy 174 Biopsy 148 Nivolumab 119 Carboplatin 98 Radiotherapy 92 Paclitaxel 84 venetoclax 82 Cisplatin 81 fludarabine phosphate 79 Gemcitabine 79 Injections 69 Ipilimumab 63 Dexamethasone 61 atezolizumab 59 Bevacizumab 59 Cetuximab 57 Azacitidine 56 Radiation 55 Fluorouracil 55 durvalumab 54 Radiosurgery 52 Temozolomide 47 Rituximab 44 Oxaliplatin 44 Irinotecan 43 Docetaxel 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Adenosine Diphosphate × 1 year × Clear all

NCT03109080 2025-11-24

RadioPARP

Institut Curie

Phase 1 Completed

Radiation Injuries, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡